OPPENHEIMER ASSET MANAGEMENT INC. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$483,767
-22.3%
2,861
-0.3%
0.01%
-22.2%
Q2 2023$622,577
+15.8%
2,871
-3.0%
0.01%
+12.5%
Q1 2023$537,836
+34.7%
2,961
+45.7%
0.01%
+33.3%
Q4 2022$399,288
+14.7%
2,032
+31.3%
0.01%0.0%
Q3 2022$348,0001,5480.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders